TSE:4506Pharmaceuticals
Sumitomo Pharma (TSE:4506) Reports Strong First Quarter Earnings, Is The Discount Too Deep?
Sumitomo Pharma (TSE:4506) drew investor attention after reporting first quarter 2026 earnings, with sales of ¥129,495 million, net income of ¥16,997 million and basic earnings per share of ¥39.02 from continuing operations.
See our latest analysis for Sumitomo Pharma.
The earnings release comes after a mixed price pattern for Sumitomo Pharma, with the share price up 3.86% over one day and 5.86% over seven days, yet down 45.35% on a year to date basis. The 3 year total shareholder return of...